IntriCon Corporation

IntriCon Corporation

IIN

IINIntriCon Corporation US flag

NASDAQ Global Market

24.23

USD

+0.03

- -

IntriCon Corporation

IIN

(NASDAQ Global Market)

Recent

price

24.23

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

No data availableFinancial data will appear here once available

Similar Companies: Poly Medicure Limited (POLYMED.NS)
Nipro Corporation (8086.T)
NanoString Technologies, Inc. (NSTG)
Koninklijke Philips N.V. (PHIA.DE)
Ansell Limited (ANSLY)
Tevano Systems Holdings Inc. (TEVNF)
Business: IntriCon Corporation IntriCon Corporation (NASDAQ:IIN) serves as a contract development and manufacturing organization (CDMO) focused exclusively on micromedical devices, designing, developing, engineering, manufacturing, and packaging high-precision components, subassemblies, and final products for medical device original equipment manufacturers (OEMs); its core offerings encompass precision molding including needle and insert molding, microelectronics assembly with ultra-fine pitch circuits down to 01005 components, custom electromagnetic sensors and assemblies, microcatheters and access sheaths, polymer and metal 3D printing, automation integration, and finished device packaging with automated vision inspection. The company targets high-growth medical markets such as diabetes management, neuromodulation, cardiology, orthopedics, peripheral vascular, interventional pulmonology, electrophysiology, advanced optics, surgical energy, vascular disease, drug delivery, and surgical navigation, serving customers including OEMs, startups, and research institutions with scalable production from prototypes to tens of millions of units annually. Founded in 1977 and headquartered in Arden Hills, Minnesota, with previous facilities in the United States (Minnesota, Illinois, California), Singapore, Indonesia, and Germany, IntriCon operates globally across four countries and maintains ISO 13485 certification and FDA registration, producing over 250 million components and assemblies per year with more than 1,000 employees. In recent major developments, Altaris Capital Partners acquired IntriCon in 2022 for $24.25 per share in a $241 million equity transaction, marking its transition to private ownership; in September 2024, the company divested its Hearing Health business to Huizhou Jinghao Medical Technology Co., Ltd., sharpening its 100% focus on non-hearing micromedical solutions; and in October 2025, IntriCon combined with Minnetronix Medical to form Forj Medical, a vertically integrated CDMO headquartered in Arden Hills, Minnesota, with expanded operations across six facilities in the United States, Indonesia, Singapore, and Costa Rica, enhancing end-to-end capabilities in system design, microelectronics, precision molding, and advanced manufacturing.

Company News